Skip to main content
SpringerLink
Log in

Was muss der Intensivmediziner über den implantierbaren Kardioverter/Defibrillator wissen

What must intensive care physicians know about implantable cardioverter defibrillator?

  • Leitthema
  • Published:
Medizinische Klinik - Intensivmedizin und Notfallmedizin Aims and scope Submit manuscript

Zusammenfassung

Der erste implantierbare Kardioverter/Defibrillator (ICD) wurde im Jahr 1980 in den USA implantiert. Nach Publikation der Multicenter-automatic-defibrillator-implantation(MADIT)-Studie-I und der Antiarrhythmics-versus-implantable-defibrillators(AVID)–Studie zur Primärprophylaxe bei Hochrisikopatienten und Sekundärprophylaxe nach überlebtem plötzlichen Herztod explodierten weltweit die Implantationszahlen. Nachdem immer ältere Patienten ICD erhalten, werden auch häufiger ICD-Patienten auf Intensivstationen und in Notfalleinheiten behandelt. Deshalb müssen Notfall- und Intensivmediziner mit diesen Geräten gut vertraut sein. Dieser Artikel gibt einen Literaturüberblick und behandelt insbesondere ICD-Fehlfunktionen und Notfälle im Zusammenhang mit ICD.

Abstract

The first implantable cardioverter defibrillator (ICD) was implanted in the USA in 1980. After the publication of the landmark studies MADIT I and AVID (primary prevention in high risk patients and secondary prevention after sudden cardiac death) implantation rates dramatically increased worldwide. Due to the increasing number of implantations in elderly patients, intensive care units and emergency departments are confronted more often with patients with ICDs. Therefore, intensive care practitioners have to be familiar with these devices. This article summarizes the current literature and focuses on the management of emergencies and malfunction of ICDs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Birnie DH, Parkash R, Exner DV et al (2012) Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee. Circulation 125:1217–1225

    Article  PubMed  Google Scholar 

  2. Bovenschulte H, Schlüter-Brust K, Erdmann E et al (2012) MRI in patients with pacemaker: overview and procedural management. Dtsch Arztebl Int 109:270–275

    PubMed  Google Scholar 

  3. Carbucicchio C, Santamaria M, Trevisi N et al (2008) Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators short- and long-term outcomes in a prospective single-center study. Circulation 19:123117:462–448

    Google Scholar 

  4. Crossley GH, Poole JE, Rozner MA et al (2011) The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm 7:1114–1154

    Article  Google Scholar 

  5. Brignole M, Auricchio A, Baron Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europ Heart J: 2281-2329

    Google Scholar 

  6. Deyell MW, Qi A, Chakrabarti S et al (2013) Prognostic impact of inappropriate defibrillator shocks in a population cohort. Heart 99: 1250-1255

    Article  PubMed  Google Scholar 

  7. Dichtl W, Wolber T, Paoli U et al (2011) Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol 34:433–436

    Article  PubMed  Google Scholar 

  8. Gombotz H, Anelli Monti M, Leitgeb N et al (2009) Perioperatives Management von Patienten mit implantiertem Schrittmacher oder Kardioverter/Defibrillator. Anästhesist 58:485–498

    Article  CAS  Google Scholar 

  9. Greenspon AJ, Rhim ES, Mark G et al (2008) Lead-associated endocarditis: the important role of methicillin-resistant Staphyloccocus aureus. Pacing Clin Electrophysiology 31:548–553

    Article  Google Scholar 

  10. Hauser RG, Kallinen LM, Almquist AK et al (2007) Early failure of a small-diameter high voltage implantable cardioverter defibrillator lead. Heart Rhyhtm 4:154–160

    Article  Google Scholar 

  11. Jacob S, Panaich SS, Maheshwari R et al (2011) Clinical applications of magnets on cardiac rhythm management devices. Europace 9:1222–1230

    Article  Google Scholar 

  12. Kleemann T, Becker T, Doenges K et al (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of 10 years. Circulation 115:2474–2480

    Article  PubMed  Google Scholar 

  13. Kleemann T, Hochadel M, Strauss M et al (2012) Comparison between atrial fibrillation-triggered implantable Cardioverter-defibrillator (ICD) Shocks and inappropriate Shocks caused by lead fracture: different impact on prognosis in clinical practice. J Cardiovasc Electrophysiol 23:735–740

    Article  PubMed  Google Scholar 

  14. Kowalski M, Huizar JF, Kaszala K et al (2008) Problems with cardiac device therapy. Cardiol Clin 26:441–458

    Article  PubMed  Google Scholar 

  15. Lee DS, Krahn AD, Healey JS et al (2010) Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol 55:774–782

    Article  PubMed  Google Scholar 

  16. Manegold JC, Israel CW, Ehrlich JR et al (2007) External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application. Eur Heart J 28:1731–1738

    Article  PubMed  Google Scholar 

  17. Marinskis G, Bongiorni MG, Dagres N et al (2012) Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey. Europace 14:1807–1809

    Article  PubMed  Google Scholar 

  18. Maytin M, Epstein LM (2012) Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead. Heart Rhythm 9:1446–1451

    Article  PubMed  Google Scholar 

  19. McPherson CA, Manthous C (2004) Permanent Pacemakers and Implantable Defibrillators – considerations for Intensivists. Am J Respir Crit Care Med 170:933–940

    Article  PubMed  Google Scholar 

  20. Morrison TB, Friedman PA, Kallinen et al (2011) Impact of implanted recalled sprint Fidelis lead on patient mortality. J Am Coll Cardiol 58:278–83

    Article  PubMed  Google Scholar 

  21. Moss AJ, Hall WJ, Cannom DS, Daubert JP et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–1940

    Article  PubMed  CAS  Google Scholar 

  22. Nowak B, Israel CW, Bänsch D et al (2010) Empfehlungen zum Einsatz von Elektrokautern bei Patienten mit Herzschrittmachern und implantierten Defibrillatoren. Kardiologe 4:383–388

    Article  Google Scholar 

  23. Poole JE, Johnson GW, Hellkamp AS et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017

    Article  PubMed  CAS  Google Scholar 

  24. Roguin A, Schwitter J, Vahlhaus C et al (2008) Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 10:336–346.

    Article  PubMed  Google Scholar 

  25. Sesselberg HW, Moss A, McNitt S et al (2007) Ventricular arrhythmia storms in postinfarkt patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 4:1395–1402

    Article  PubMed  Google Scholar 

  26. Sohail MR, Uslan DZ, Khan AH et al (2007) Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 49:1851–1859

    Article  PubMed  Google Scholar 

  27. Streitner F, Kuschyk J, Veltmann C et al (2011) Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators. Europace 13:668–274

    Article  PubMed  Google Scholar 

  28. Rees JB van, Bie MK de, Thijssen J et al (2011) Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J Am Coll Cardiol 58:995–1000

    Article  PubMed  Google Scholar 

  29. Rees JB van, Borleffs CJ, Bie MK de et al (2011) Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 57:556–562

    Article  PubMed  Google Scholar 

  30. Valk SD, Theuns DA, Jordaens L (2013) Long-term performance of the St. Jude Riata 1580–1582 ICD lead family. Neth Heart J 21:127–134

    Article  PubMed  CAS  Google Scholar 

  31. The antiarrhythmics versus implantable defibrillators (AVID) investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337:1576–1583

    Article  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. E. Gatterer erhielt Vortragshonorare von den Firmen Biotronik, Medtronic und St. Jude Medical sowie Kongressreisekostenerstattung durch die Firmen Biotronic, Boston Scientific, Medtronic und St. Jude Medical.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. 2. Medizinische Abteilung mit Intensivstation, KA Rudolfstiftung, Juchgasse 25, 1030, Wien, Österreich

    E. Gatterer

Authors
  1. E. Gatterer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Gatterer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gatterer, E. Was muss der Intensivmediziner über den implantierbaren Kardioverter/Defibrillator wissen. Med Klin Intensivmed Notfmed 108, 569–577 (2013). https://doi.org/10.1007/s00063-013-0230-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-013-0230-6

Schlüsselwörter

Keywords

Search

Navigation